Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK
Crossref DOI link: https://doi.org/10.1007/s40258-016-0244-3
Published Online: 2016-04-29
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Montgomery, Stephen http://orcid.org/0000-0002-8481-5850
Kusel, Jeanette
Allen, Felicity
Adlard, Nicholas
Funding for this research was provided by:
Novartis Pharmaceuticals UK Limited (GB)
Text and Data Mining valid from 2016-04-29